MAPT and Alzheimer disease: Consistent with the proposed biological definition of AD [36] and due to the known variability of AD neuropathology from region to region, human dorsolateral prefrontal cortex tissue specimens were scored neuropathologically for amyloid and tau pathologies as an “AT” score (Table S1) to obtain a series of annotated tissues with variable AD neuropathology.